Informations techniques
Exploitant
Winthrop médicaments (Groupe Sanofi Aventis)
Présentation
DILRENE LP 300 mg, gélule à libération prolongée
B/ 28 - (Code CIP : 331 991-4)
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
sLAHkhPMLAJbqBdA